Clinical Trial: GliomaAI-MG: MRI-Based Detection of Molecular Glioblastoma

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664254) titled 'GliomaAI-MG: MRI-Based Detection of Molecular Glioblastoma' on June 13.

Brief Summary: The goal of this observational study is to learn whether an artificial intelligence system called GliomaAI-MG can help detect a specific molecular type of brain tumour called molecular glioblastoma using routine MRI scans. The study uses previously collected and fully anonymised MRI data from 1,372 patients from 13 institutions in the Cancer Imaging Archive (TCIA).

The main questions it aims to answer are:

* How accurately can GliomaAI-MG identify molecular glioblastoma from MRI scans?

* How well does the system perform across data from differe...